Research Papers

25 of 69 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review…
Irungu E; Khoza N; Velloza J.
Curr HIV/AIDS Rep (Unknown)
Published: 2021
Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations - Community Mobile Clinics, Peer-Supported, P…
Rousseau E; Julies RF; Madubela N; Kassim S.
Curr HIV/AIDS Rep (Unknown)
Published: 2021
1/6 Transparent
Lessons Learned from Longer Acting Reversible Contraception Applied to Longer Acting HIV Prevention Technologies.
Logan R; Seidman D.
Curr HIV/AIDS Rep (Unknown)
Published: 2021
1/6 Transparent
Funding Declared
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations.
Zheng L; Tierney C; Bosch RJ.
Curr HIV/AIDS Rep (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters.
Wechsberg WM; Browne FA; Bonner CP; Washio Y; Howard BN; van der Drift I.
Curr HIV/AIDS Rep (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies.
Gravett RM; Marrazzo JM.
Curr HIV/AIDS Rep (Unknown)
Published: 2021
1/6 Transparent
Interventions Addressing Depression and HIV-Related Outcomes in People with HIV.
Mendez NA; Mayo D; Safren SA.
Curr HIV/AIDS Rep (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Ethical Implications of eHealth Tools for Delivering STI/HIV Laboratory Results and Partner Notifications.
Godongwana M; Chewparsad J; Lebina L; Golub J; Martinson N; Jarrett BA.
Curr HIV/AIDS Rep (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Recruitment of US Adolescents and Young Adults (AYA) into Human Immunodeficiency Virus (HIV)-Related Behavioral Researc…
Navarra AD; Handschuh C; Hroncich T; Jacobs SK; Goldsamt L.
Curr HIV/AIDS Rep (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies.
Siegler AJ; Steehler K; Sales JM; Krakower DS.
Curr HIV/AIDS Rep (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Understanding Engagement in HIV Programmes: How Health Services Can Adapt to Ensure No One Is Left Behind.
Grimsrud A; Wilkinson L; Eshun-Wilson I; Holmes C; Sikazwe I; Katz IT.
Curr HIV/AIDS Rep (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
A Cascade of Interventions to Promote Adherence to Antiretroviral Therapy in African Countries.
Jopling R; Nyamayaro P; Andersen LS; Kagee A; Haberer JE; Abas MA.
Curr HIV/AIDS Rep (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Social Network Interventions for HIV Transmission Elimination.
Pagkas-Bather J; Young LE; Chen YT; Schneider JA.
Curr HIV/AIDS Rep (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
A Systematic Review of Technology-Assisted HIV Testing Interventions.
Horvath KJ; Walker T; Mireles L; Bauermeister JA; Hightow-Weidman L; Stephenson R.
Curr HIV/AIDS Rep (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
The Brain Retains: Nonhuman Primate Models for Pediatric HIV-1 in the CNS.
Obregon-Perko V; Bricker K; Chahroudi A.
Curr HIV/AIDS Rep (Unknown)
Published: 2020
History of the HIV Epidemic in China.
Wu Z; Chen J; Scott SR; McGoogan JM.
Curr HIV/AIDS Rep (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
HIV and Solid Organ Transplantation: Where Are we Now.
Botha J; Fabian J; Etheredge H; Conradie F; Tiemessen CT.
Curr HIV/AIDS Rep (Unknown)
Published: 2019
1/6 Transparent
Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
Rich KM; Bia J; Altice FL; Feinberg J.
Curr HIV/AIDS Rep (Unknown)
Published: 2018
1/6 Transparent
Sex Differences in HIV Infection.
Scully EP.
Curr HIV/AIDS Rep (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Genetic Cluster Analysis for HIV Prevention.
Grabowski MK; Herbeck JT; Poon AFY.
Curr HIV/AIDS Rep (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Redefining Aging in HIV Infection Using Phenotypes.
Stoff DM; Goodkin K; Jeste D; Marquine M.
Curr HIV/AIDS Rep (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System.
Bhiman JN; Lynch RM.
Curr HIV/AIDS Rep (Unknown)
Published: 2017
1/6 Transparent
NK Cells in HIV Disease.
Scully E; Alter G.
Curr HIV/AIDS Rep (Unknown)
Published: 2016
1/6 Transparent
How to Define the Latent Reservoir: Tools of the Trade.
Barton KM; Palmer SE.
Curr HIV/AIDS Rep (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.
Gelman BB.
Curr HIV/AIDS Rep (Unknown)
Published: 2015
1/6 Transparent